Ketamine for OCD
732 providers treating ocd
Providers experienced in treating obsessive-compulsive disorder (OCD) with ketamine therapy, offering relief for treatment-resistant cases.
Ketamine Therapy for OCD
If you have obsessive-compulsive disorder that has not responded to SSRIs, clomipramine, or exposure and response prevention (ERP) therapy, ketamine is being studied as a potential alternative. OCD is one of the more treatment-resistant psychiatric conditions, with about 40-60% of patients not achieving full remission from first-line treatments, which has led researchers to explore glutamate-based interventions like ketamine. OCD affects roughly 2-3% of the population and can be severely disabling when standard treatments are insufficient.
The evidence for ketamine in OCD is more preliminary than for depression but shows promise. A landmark study by Rodriguez and colleagues at Columbia University found that a single ketamine infusion produced rapid and significant reductions in OCD symptoms, with effects emerging within hours. About half of the participants experienced a meaningful response, and in some cases the effects lasted for more than a week after a single infusion. These results were particularly striking because participants had severe, medication-resistant OCD.
The connection between glutamate and OCD has been a productive area of research. Brain imaging studies have found elevated glutamate levels in the cortico-striato-thalamo-cortical (CSTC) circuits of people with OCD, which are the circuits believed to drive obsessive thoughts and compulsive behaviors. This makes glutamate-targeting treatments like ketamine a logical avenue to explore for this condition, and distinguishes the rationale from simply borrowing a depression treatment.
Treatment protocols for OCD are still being standardized. Most clinics offering ketamine for OCD follow protocols similar to those used for depression, but some providers are adjusting dosing based on emerging research. If you pursue this option, you should understand that you are in somewhat earlier territory compared to ketamine for depression, where protocols are more established. Not all ketamine clinics accept OCD patients, so you may need to specifically ask about their experience with this condition.
As with other conditions, ketamine is most likely to be helpful as part of a broader treatment plan. Some researchers believe ketamine could be especially effective when combined with ERP therapy, since the neuroplasticity ketamine promotes might help the brain form new response patterns to obsessive triggers more readily. This combination approach is an active area of study, and early results suggest the pairing may be more effective than either treatment alone.
How Ketamine Treats OCD
OCD involves dysfunction in the CSTC circuits, with abnormal glutamate signaling playing a central role. Ketamine blocks NMDA receptors, which modulates glutamate transmission in these circuits. This may temporarily normalize the overactive signaling patterns that drive obsessive thoughts and compulsive urges, providing rapid but time-limited symptom relief.
Beyond the direct glutamate effects, ketamine's promotion of synaptic plasticity through BDNF and mTOR pathways may help the brain restructure the rigid neural patterns characteristic of OCD. This plasticity window could be particularly valuable when paired with behavioral therapy, potentially making it easier for you to resist compulsions and build new cognitive habits.
Who Is a Candidate?
You may be a candidate if you have a formal OCD diagnosis and have not responded adequately to at least two SSRI trials at appropriate doses, a trial of clomipramine, or an adequate course of ERP therapy. Your provider should have experience treating OCD specifically, as the assessment and treatment considerations differ from depression. People with co-occurring psychotic features or active substance use disorders may not be appropriate candidates.
Because the evidence base is still developing, you should have a clear understanding that ketamine for OCD is considered investigational. Your provider should be transparent about what is known and what remains uncertain, and you should feel comfortable proceeding with that level of evidence before starting treatment.
Frequently Asked Questions
- The evidence is less extensive for OCD than for depression. Response rates in studies have been roughly 40-50% for OCD versus 60-70% for treatment-resistant depression. However, given how difficult OCD can be to treat, even a 40-50% response rate in resistant cases is considered significant by researchers.
- Most providers recommend continuing ERP alongside ketamine. There is a theoretical basis for combining the two: ketamine's neuroplasticity effects may make the brain more receptive to the behavioral changes ERP promotes. Discuss the timing and coordination of both treatments with your providers.
- Studies have generally measured overall OCD symptom severity rather than obsessions and compulsions separately. The available data suggests ketamine reduces both components, though some patients report more relief from intrusive thoughts than from compulsive behaviors. Individual responses vary considerably.